Literature DB >> 12493164

Cardiac magnetic resonance spectroscopy.

Stefan Neubauer1.   

Abstract

This review describes recent advances in cardiac magnetic resonance spectroscopy (MRS). MRS allows noninvasive characterization of the metabolic state of cardiac muscle, in both animal and human models. Recent experimental MRS studies have allowed new insights into the essential role of energetics in heart failure. Various new studies suggest a rapidly growing role of MRS for phenotyping new genetically modified mouse models, and recent methodologic advances include development of absolute quantification of high-energy phosphates, measurement of ATP turnover rates and thermodynamic parameters (such as free ADP and free energy change of ATP hydrolysis), and improved acquisition sequences. New patient studies demonstrate the potential value of MRS as a clinical diagnostic tool in patients with ischemic heart disease, heart failure, cardiac transplantation, valve disease, and genetic cardiomyopathy.

Entities:  

Mesh:

Year:  2003        PMID: 12493164     DOI: 10.1007/s11886-003-0041-0

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  30 in total

1.  Accurate phosphorus metabolite images of the human heart by 3D acquisition-weighted CSI.

Authors:  R Pohmann; M von Kienlin
Journal:  Magn Reson Med       Date:  2001-05       Impact factor: 4.668

2.  Human cardiac high-energy phosphate metabolite concentrations by 1D-resolved NMR spectroscopy.

Authors:  P A Bottomley; E Atalar; R G Weiss
Journal:  Magn Reson Med       Date:  1996-05       Impact factor: 4.668

3.  An increase in the myocardial PCr/ATP ratio in GLUT4 null mice.

Authors:  Robert G Weiss; John C Chatham; Dimitrios Georgakopolous; Maureen J Charron; Theo Wallimann; Laurence Kay; Bernd Walzel; Yibin Wang; David A Kass; Gary Gerstenblith; V P Chacko
Journal:  FASEB J       Date:  2002-04       Impact factor: 5.191

4.  Detection of low phosphocreatine to ATP ratio in failing hypertrophied human myocardium by 31P magnetic resonance spectroscopy.

Authors:  M A Conway; J Allis; R Ouwerkerk; T Niioka; B Rajagopalan; G K Radda
Journal:  Lancet       Date:  1991-10-19       Impact factor: 79.321

5.  Phosphorus NMR studies on perfused heart.

Authors:  P B Garlick; G K Radda; P J Seeley
Journal:  Biochem Biophys Res Commun       Date:  1977-02-07       Impact factor: 3.575

6.  Aortic valve replacement in patients with aortic valve stenosis improves myocardial metabolism and diastolic function.

Authors:  H P Beyerbacht; H J Lamb; A van Der Laarse; H W Vliegen; F Leujes; M G Hazekamp; A de Roos; E E van Der Wall
Journal:  Radiology       Date:  2001-06       Impact factor: 11.105

7.  Concentrations of human cardiac phosphorus metabolites determined by SLOOP 31P NMR spectroscopy.

Authors:  M Meininger; W Landschütz; M Beer; T Seyfarth; M Horn; T Pabst; A Haase; D Hahn; S Neubauer; M von Kienlin
Journal:  Magn Reson Med       Date:  1999-04       Impact factor: 4.668

8.  31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure.

Authors:  S Neubauer; T Krahe; R Schindler; M Horn; H Hillenbrand; C Entzeroth; H Mader; E P Kromer; G A Riegger; K Lackner
Journal:  Circulation       Date:  1992-12       Impact factor: 29.690

9.  31P NMR spectroscopy detects metabolic abnormalities in asymptomatic patients with hypertrophic cardiomyopathy.

Authors:  W I Jung; L Sieverding; J Breuer; T Hoess; S Widmaier; O Schmidt; M Bunse; F van Erckelens; J Apitz; O Lutz; G J Dietze
Journal:  Circulation       Date:  1998-06-30       Impact factor: 29.690

10.  Impairment of energy metabolism in intact residual myocardium of rat hearts with chronic myocardial infarction.

Authors:  S Neubauer; M Horn; A Naumann; R Tian; K Hu; M Laser; J Friedrich; P Gaudron; K Schnackerz; J S Ingwall
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

View more
  5 in total

1.  [3 tesla magnetic resonance imaging in children and adults with congenital heart disease].

Authors:  I Voges; M Jerosch-Herold; M Helle; C Hart; H-H Kramer; C Rickers
Journal:  Radiologe       Date:  2010-09       Impact factor: 0.635

2.  Zidovudine-Mediated Autophagy Inhibition Enhances Mitochondrial Toxicity in Muscle Cells.

Authors:  H Lin; M V Stankov; J Hegermann; R Budida; D Panayotova-Dimitrova; R E Schmidt; G M N Behrens
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

3.  AZT-induced mitochondrial toxicity: an epigenetic paradigm for dysregulation of gene expression through mitochondrial oxidative stress.

Authors:  Christopher A Koczor; Zhe Jiao; Earl Fields; Rodney Russ; Tomika Ludaway; William Lewis
Journal:  Physiol Genomics       Date:  2015-07-21       Impact factor: 3.107

4.  Metabolomic approach to profile functional and metabolic changes in heart failure.

Authors:  Martino Deidda; Cristina Piras; Christian Cadeddu Dessalvi; Emanuela Locci; Luigi Barberini; Federica Torri; Federica Ascedu; Luigi Atzori; Giuseppe Mercuro
Journal:  J Transl Med       Date:  2015-09-12       Impact factor: 5.531

Review 5.  Emerging techniques in atherosclerosis imaging.

Authors:  Maaz Bj Syed; Alexander J Fletcher; Rachael O Forsythe; Jakub Kaczynski; David E Newby; Marc R Dweck; Edwin Jr van Beek
Journal:  Br J Radiol       Date:  2019-09-10       Impact factor: 3.039

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.